Skip to content
Generic Drugs Forum 2026 Overall Evaluation
Event Evaluation & Certificate of Attendance
*
1.
Please provide the email address
you used to register for the event
:
(Required.)
*
2.
How satisfied were you with these aspects of the event?
(Required.)
Very Disappointed
Disappointed
Neutral
Satisfied
Very Satisfied
N/A
Event registration process
Very Disappointed
Disappointed
Neutral
Satisfied
Very Satisfied
N/A
Q&A opportunities with the presenters
Very Disappointed
Disappointed
Neutral
Satisfied
Very Satisfied
N/A
Event on-site facilities (if you attended in person)
Very Disappointed
Disappointed
Neutral
Satisfied
Very Satisfied
N/A
Event online platform (if you attended virtually)
Very Disappointed
Disappointed
Neutral
Satisfied
Very Satisfied
N/A
*
3.
How likely are you to recommend virtual attendance of SBIA events to your colleagues?
(Required.)
Likely
Neither likely or unlikely
Unlikely
I attended in person
*
4.
Was this event valuable to you?
(Required.)
Yes
No
5.
If you chose "Yes" to the above question why did you rate the event as valuable (choose all that apply):
Event's topics were relevant to what I do
I learned something new and important during this event
This information will be helpful to my colleagues
What I learned will have a positive impact on what I do
6.
Please provide any comments to help us improve future events
(topics, virtual attendance suggestions, other suggestions, etc.):
*
7.
Do you believe that a comprehensive, discipline-based, and difficulty-ranked generic drug review workshop/curriculum, aligned with the FDA’s generic drug review process, would improve knowledge retention, enhance regulatory understanding, and better prepare industry professionals?
(Required.)
Yes – This approach would improve knowledge retention, reinforce regulatory consistency, and enhance learning outcomes.
No – This approach may not be as effective or could be improved in other ways.
